Skip to Content.
Sympa Menu

usatlas-hllhc-l2deputymgmt-nsf-l - Re: [Usatlas-hllhc-l2deputymgmt-nsf-l] Please provide COVID BCP narrative describing COVID changes by COB Dec 18

usatlas-hllhc-l2deputymgmt-nsf-l AT lists.bnl.gov

Subject: U.S. ATLAS HL-LHC Upgrade Level 2 and Deputies-NSF only Management Mailing List

List archive

Chronological Thread  
  • From: Michael Tuts <tuts AT pmtuts.net>
  • To: "usatlas-hllhc-l2deputymgmt-nsf-l AT lists.bnl.gov" <usatlas-hllhc-l2deputymgmt-nsf-l AT lists.bnl.gov>
  • Cc: "us-atlas-hllhc-pmgmt-l AT lists.bnl.gov" <us-atlas-hllhc-pmgmt-l AT lists.bnl.gov>
  • Subject: Re: [Usatlas-hllhc-l2deputymgmt-nsf-l] Please provide COVID BCP narrative describing COVID changes by COB Dec 18
  • Date: Wed, 16 Dec 2020 14:52:32 +0000

Sorry for the typo in the body of the text. The due date is Friday Dec 18 (not Dec 17).

 

From: Michael Tuts
Sent: Wednesday, December 16, 2020 9:51 AM
To: usatlas-hllhc-l2deputymgmt-nsf-l AT lists.bnl.gov
Cc: us-atlas-hllhc-pmgmt-l AT lists.bnl.gov; Amy Garwood - Nevis Labs (agarwood AT nevis.columbia.edu) <agarwood AT nevis.columbia.edu>
Subject: Please provide COVID BCP narrative describing COVID changes by COB Dec 18

 

Dear NSF scope L2s,

 

We have just held a meeting with NSF regrading getting NSF approval of the NSF COVID BCP. They have no issues with the numbers or process, but they require more documentation regarding the description of the COVID changes in your subsystems down to L3. The sooner we get this done, the sooner we can get it approved by NSF, so to that end can you please provide it by COB Friday December 17 (sorry for the short notice, but as usual we get short notice from NSF). In addition, this information will be necessary for an eventual re-baselining to address the COVID needs – so writing this down this while it is still fresh in your minds will help with the future required documentation. The format of it should be along the lines of a “BOE”. The snip provided below may be helpful as it splits the costs into direct, fringe, overhead, escalation.

 

  • For each L3, provide the description of the COVID change in the BCP (e.g. what was the work that was delayed and why/how was it delayed by lab/office closures; what tasks were not started and moved to the future, etc)
  • In evaluating our BCP and trying to clearly understand what is COVID related and what is not COVID related, NSF would also like to have a description of the non-COVID delays and/or resource increases during the same period covered by this COVID BCP (for example NSF monitors our baseline milestones and the working schedule milestones). So include that in a separate non-COVID section/paragraph.
  • If resources changed, indicate why they changed (e.g. efficiency and how you estimated that efficiency, or…)
  • If it is a simple schedule shift, then presumably the associated cost increase is an escalation effect only, etc
  • If you eliminated travel, specify how much that was and why it was eliminated

 

 

 

Thanks,

Your PO

 

 






Archive powered by MHonArc 2.6.24.

Top of Page